Biolevox™ HA

  • Biolevox™ HA 1
  • Biolevox™ HA 2
Product Description

The Biolevox™ HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications.

  • Biolevox™ HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom relief and improved joint function lasting up to 12 months.
  • Biolevox™ HA 2.2% provides 44 mg HA in 2 ml through a 3-injection course. Its USP is versatility: it can be used in different joints and supports pain relief and mobility after arthroscopy.
  • Biolevox™ HA MINI is designed for small joints, including the hand, foot, ankle and facet joints. Its USP is precise viscosupplementation that relieves pain and improves mobility for months.
  • Biolevox™ HA TENDON is designed for tendinopathy and enthesopathy. Its USP is targeted anti-catabolic action that supports tendon ...

Read more Show less

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
View company profile
Categories
more categories Show less
Specifications
  • Details
    The Biolevox™ HA product family is based on hyaluronic acid:
  • Biolevox™ HA ONE – 120 mg HA / 4.8 ml; single-injection therapy for osteoarthritic joints, helping reduce pain and stiffness and improve mobility.
  • Biolevox™ HA 2.2% – 44 mg HA / 2 ml; versatile intra-articular therapy for different joints, including the knee, elbow and shoulder; also used after arthroscopy.
  • Biolevox™ HA MINI – 16 mg HA / 1 ml; designed for precise injections into small joints, including the ankle, facet and hand joints.
  • Biolevox™ HA TENDON – 32 mg HA / 2 ml; designed for painful tendon disorders, including tendinopathy and enthesopathy.
  • Selling Points
    Bone & Joint Health; Brand Name; Biolevox™ HA ONE
    • Clinically confirmed effect up to 12 months
    • Reduces pain and stiffness, improves mobility
    • Highly purified, non-animal HA from bacterial fermentation   
    Biolevox™ HA 2.2%
    • Versatile use in different joints
    • Three-injection therapy at weekly intervals
    • Clinically effective after arthroscopic procedures 
    Biolevox™ HA MINI
    • Designed specifically for small joints
    • Precise intra-articular administration
    • Helps reduce pain and improve joint mobility for months 
    Biolevox™ HA TENDON
    • Designed for tendinopathy and enthesopathy
    • Strong anti-catabolic and biological action
    • Supports tendon healing, pain relief and functional recovery
  • Supplied from
    Poland
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Biovico Sp. z o.o.

    • Country/Region:
      Poland
    • Founded:
      2008
    • On CPHI since:
      2015
    • Certificates:
      5
    • Employees:
      100 - 249
    Company types
    CMO/CDMO
    Licensee
    Manufacturer/Innovator
    Wholesale/Retail
    Primary activities
    Medical Devices
    View company profile

    More Products from Biovico Sp. z o.o. (12)

    • Lipotris™

      Product Lipotris™

      Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris™ therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage surfac...
    • Xerthra™ kits

      Product Xerthra™ kits

      Xerthra™ is a family of high-performance separation devices for preparing autologous, blood-derived injectable products. Made from Makrolon® polycarbonate with very low surface energy, Xerthra™ minimizes protein/cell binding to the device surface — unlike tube-based kits — ensuring maximum recovery of plat...
    • Wint™ kit

      Product Wint™ kit

      Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...
    • FLAVYA™

      Product FLAVYA™

      Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.
      Two v...
    • DKK DERM™ kit

      Product DKK DERM™ kit

      DKK DERM™ kit is designed to obtain an autologous blood-derived product enriched with the DKK-1 protein (DKK-PRP). The DKK DERM™ separation device features an innovative borosilicate platelet activator that selectively induces platelet activation, leading to the release of hig...
    • Monoshot™ HA+PRP

      Product Monoshot™ HA+PRP

      Monoshot™ HA+PRP is an innovative kit combining hyaluronic acid (HA) with platelet-rich plasma (PRP) for intra-articular injection therapy. HA delivers mechanical lubrication and anti-inflammatory action by reducing matrix metalloproteinase production, while PRP — prepared using the dedicated Monoshot™ sep...
    • Xerthra™ BMAC

      Product Xerthra™ BMAC

      Xerthra™ BMAC is an innovative procedure set for separating and concentrating bone marrow aspirate to obtain a concentrated bone marrow fraction (BMAC), used for local injection to enhance tissue regeneration. Its uniquely designed separation devices deliver BMAC with 5 times more concentrated mesenchymal ...
    • AOORA™ kits

      Product AOORA™ kits

      Three AOORA™ procedure packs designed for isolation and separation of high quality blood derived products. The obtained platelet-rich plasma (PRP) contains minimum 1 milion of platelets in 1 μl of plasma, which has the direct impact on the high amount of growth factors delivered in order to revitalize skin...
    • Flavya™ Post Treatment products

      Product Flavya™ Post Treatment products

      Flavya™ Post-Treatment Products are biocellulose-based medical devices infusedwith hyaluronic acid. Due to their occlusive properties, they form a protective barrieron the skin, which is particularly beneficial after medical esthetic treatments.Additionally, their cooling effect helps soothe irritation and...
    • Supplements

      Product Supplements

      Biolevox™ Complex (90 film-coated capsules) supplements the diet with ingredients found in joint structures thus supports the their functioning.
      Chondrovox™ (60 capsules) formulation contains chondroitin sulfate that occurs naturally in joint cartilage. Chondroitin supplementation sup...
    • Progum™

      Product Progum™

      Progum™ is a hyaluronic acid-based product line supporting regeneration in dental and periodontal care. Progum™ HA is a highly concentrated, non-crosslinked native hyaluronic acid (16 mg HA in a 1 mL pre-filled syringe) with physicochemical parameters optimized to promote soft periodontal tissue regen...
    • Ossylbone™

      Product Ossylbone™

      Ossylbone™ is a fully biocompatible, biodegradable and safe material that mimics the natural bone structure and by that its able to effectively support the regeneration of the bone tissue.The Ossylbone™ as an alloplast material is bone substitute material obtained through laboratory chemical synt...

    Biovico Sp. z o.o. resources (4)